AAML1522/CC-5013-AML-002: A Phase 2, Multicenter, Single-Arm, Open Label, Study to Evaluate the Activity, Safety, and Pharmacokinetics of Lenalidomide....

      Project: Research project

      Project Details

      StatusFinished
      Effective start/end date11/1/1610/31/20

      Funding

      • Children's Hospital of Philadelphia
      • Celgene Corporation